Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.51 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.51 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.51 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.51 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.51 |
| ▸ | ATR | Q13535 | 4/20 | 0.51 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 2/20 | 0.45 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.45 |
| ▸ | RAF1 | P04049 | 1/20 | 0.45 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.45 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | MYC | P01106 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL385924 | 0.84 | ATR (0.62) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL16750246 | 0.84 | CKS1B (0.52) | ATRKDM4ELMNASMN1; SMN2ADORA2A | |
| SCHEMBL87574 | 0.84 | CKS1B (0.55) | ATRKDM4ESMN1; SMN2CKS1BSKP1 | |
| SCHEMBL28243355 | 0.82 | CKS1B (0.53) | ATRKDM4ESMN1; SMN2CKS1BSKP1 | |
| SCHEMBL29406280 | 0.82 | CKS1B (0.53) | ATRKDM4ESMN1; SMN2CKS1BSKP1 | |
| SCHEMBL27816089 | 0.82 | CKS1B (0.53) | ATRKDM4ESMN1; SMN2CKS1BSKP1 | |
| SCHEMBL23542929 | 0.81 | GABRA1 (0.52) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL23607308 | 0.81 | ALDH1A3 (0.57) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL23234338 | 0.81 | ALDH1A3 (0.57) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL23234347 | 0.81 | ALDH1A3 (0.57) | GABRA1GABRG2GABRB3GABRA5GABRA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329903-B2 | Light-emitting element including organometallic complex including pyrazine derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| US-8329903-B2 | Light-emitting element including organometallic complex including pyrazine derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20120123117-A1 | Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-17 | — | — | US | disclosed |
| US-20120123117-A1 | Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-17 | — | — | US | disclosed |
| US-8101755-B2 | Organometallic complex including pyrazine derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8101755-B2 | Organometallic complex including pyrazine derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-20100105902-A1 | Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-04-29 | — | — | US | disclosed |
| US-20100105902-A1 | Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105902-A1 | Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex | CRY1, CRY2, LAGE3 | GABRA1 3384/4885GABRG2 2846/4885GABRB3 4162/4885 |
| US-20120123117-A1 | Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex | CRY1, CRY2, LAGE3 | GABRA1 3384/4885GABRG2 2846/4885GABRB3 4162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.